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Cardiac valves are dynamic structures, exhibiting a highly specialized architecture consisting of cells and extracellular matrix with
a relevant proteoglycan and glycosaminoglycan content, collagen and elastic ﬁbers. Biological valve substitutes are obtained from
xenogenic cardiac and pericardial tissues. To overcome the limits of such non viable substitutes, tissue engineering approaches
emerged to create cell repopulated decellularized scaﬀolds. This study was performed to determine the glycosaminoglycans
content, distribution, and disaccharides composition in porcine aortic and pulmonary valves and in pericardium before and
after a detergent-based decellularization procedure. The ﬁne structural characteristics of galactosaminoglycans chondroitin
sulfate and dermatan sulfate were examined by FACE. Furthermore, the mechanical properties of decellularized pericardium
and its propensity to be repopulated by in vitro seeded ﬁbroblasts were investigated. Results show that galactosaminoglycans
and hyaluronan are diﬀerently distributed between pericardium and valves and within heart valves themselves before and after
decellularization.Thedistributionofglycosaminoglycansisalsodependentfromthevasculardistrictandtopographiclocalization.
The decellularization protocol adopted resulted in a relevant but not selective depletion of galactosaminoglycans. As a whole, data
suggest that both decellularized porcine heart valves and bovine pericardium represent promising materials bearing the potential
for future development of tissue engineered heart valve scaﬀolds.
1.Introduction
Heart valve disease has a deep impact worldwide related
with the large number of valvular replacement opera-
tions performed every year. Typical valve substitutes are
mechanical prostheses and bioprostheses obtained from
cardiac-valvulated conduits (aortic and pulmonary root) or
pericardial tissue of porcine and bovine origin. Bioprosthetic
valves, although associated with a lower risk of thromboem-
bolism with respect to the mechanical ones, possess limited
longevity due to dystrophic calciﬁcation consequent to glu-
taraldehyde(GA)treatmentusedforpreventing rejection[1]
and suﬀer for many of the same degenerative processes that
aﬄict native valves [2]. In the last years, tissue engineering
(TE) approaches raised in response to limitations associated
with tissue and organ transplantation and with the scarcity
of available donors. Three are the components essential for
a TE substitute: cells, scaﬀolds (designed to maintain the
cells in a three-dimensional environment), and signals that
guidethegeneexpressionandECMproductionduringtissue
development [3]. The typical approach relies on the use
of acellular matrix xenografts (mostly porcine and bovine)
as scaﬀold that would ultimately become repopulated with
cells from the patient [4]. Repopulation of natural matrix
xenografts has been proposed for its greater chance of
success with respect to that of biopolymeric scaﬀolds [5, 6].
The surgical procedures, used to date for the implantation
of commercially available devices, are represented by the2 Biochemistry Research International
transcatheter aortic valve replacement (TAVI) technique and
the open chest classical method. The use of TAVI is indeed
emergingespeciallyinpatientswithsevereaorticstenosisand
multiple comorbidities that might preclude open chest valve
replacements [4]. Most of these expandable grafts are built
within pericardial tissue.
The relative amounts and distributions of glycosamino-
glycans/proteoglycans (GAGs/PGs) have been reported to be
diﬀerent according to the type of mechanical loading [7, 8].
The knowledge of the composition and distribution of the
various GAGs and PGs appears to be essential for under-
standing the relationship between structure and mechanics
of heart valve leaﬂets [9]. The inﬂuence of GAGs and PGs
on cell migration, proliferation, and diﬀerentiation is well
known, besides their role in morphogenesis, angiogenesis,
wound healing, immune responses, maintenance of tissue
viscoelasticity, and resistance to compression and tension
[7, 10, 11].
The maintenance of structural and functional ECM
integrityisofprimaryimportancefortheperformanceofthe
valve substitutes; consequently, their depletion or alteration
could be responsible for graft deterioration [12].
GAGs are capable of absorbing a large amount of water
within the tissue matrix, due to their high concentration of
negative charges and hydrophilicity. This reason led to con-
sidering them as fundamental components for the mechan-
ical behavior, given the ability to hydrate the spongiosa
layer (decreasing the shear stresses associated with cuspal
ﬂexure in valve function), and to absorb compressive forces
reducing buckling during ﬂexion [13–16]. Furthermore,
their high negative charge may reduce the calciﬁcation pro-
cess by chelating calcium ions. These observations suggest
that the loss of the GAGs might dramatically compromise
the mechanical function, structure, and/or the onset of
dystrophiccalciﬁcationofbioprostheticheartvalves[17,18].
Al o s so fG A G sh a sb e e nd e s c r i b e di nb o t hﬁ x e d
tissues, during the preparation of bioprostheses, and in
cryopreservednativetissues[19],withpossibleconsequences
on the graft performance. Reports characterizing valve
GAGs are largely referred to bioprosthetic valves and tissue-
engineered heart valves (TEHVs) [14, 16, 19], whereas
only few investigations concerned GAG distribution in the
native valve [20–22] and their ﬁne structure. The structural
properties of GAGs, such as the extent and pattern of
sulfation, the charge density, and the epimerization of their
uronic acid moiety are thought to be critical for their
function and cellular signaling [23–25]. In vivo each of them
can be modulated mediating several biological processes
that promote the interaction with diﬀerent ECM molecules
and cells. Recently, we reported the impact of detergent
based cell removal on structural components distribution
and hydration in aortic and pulmonary heart valve conduits
highlighting a relevant depletion of GAGs [26]. This study is
focused on the ﬁne structural analysis of the most abundant
galactosaminoglycans (GalAGs), that is, the chondroitin
sulfate (CS) isomers. The aim of the present study was to
characterize the distribution as well as the ﬁne structure of
GalAGs in native and decellularized porcine cardiac valves
and pericardium due to their extensive use as bioprosthetic
material in heart valve replacement. Moreover, we tested the
mechanical properties of decellularized-treated pericardium
and its propension to be repopulated by in vitro seeded
ﬁbroblasts.
2.MaterialsandMethods
2.1. Chemicals. Standard preparations of ΔDi-nonScs,2 -
acetamido-2-deoxy-3-0-(4-deoxy-α-L-threo-hex-4-enopy-
ranosyluronic acid)-4-D-galactose; ΔDi-mono6S, 2-ac-
etamido-2-deoxy-3-0-(4-deoxy-α-L-threo-hex-4-enopyran-
osyluronic acid)-6-O-sulpho-D-galactose; ΔDi-mono4S, 2-
acetamido-2-deoxy-3-0-(4-deoxy-α-L-threo-hex-4-enopy-
ranosyluronic acid)-4-O-sulpho-D-galactose were all pur-
chased from Seikagaku (Tokyo, Japan); ΔDi-nonSHA,
2-acetamido-2-deoxy-3-O-(4-deoxy-α-L-threo-hex-4-eno-
pyranosyluronic acid)-4-D-glucose; ΔDi-mono2S, 2-ac-
etamido-2-deoxy-3-O-(4-deoxy-2-O-sulpho-α-L-threo-
hex-4-enopyranosyluronic acid)-D-galactose; ΔDi-di(2,4)S,
2-acetamido-2-deoxy-3-O-(4-deoxy-2-O-sulfo-α-L-threo-
hex-4-enopyranosyluronic acid)-4-O-sulfo-D-galactose;
ΔDi-di(4,6)S, 2-acetamido-2-deoxy-3-O-(4-deoxy-α-L-
threo-hex-4-enopyranosyluronic acid)-4,6-O-sulpho-D-gal-
actose were purchased from Dextra Laboratories. Papain
fromPapayalatex (EC3.4.22.2), chondroitin ABClyasefrom
Proteus vulgaris (EC 4.2.2.4), chondroitin AC lyase from
Arthrobacter Aurescens (4.2.2.5), AMAC (>98%), glacial
acetic acid, sodium acetate, chloride acid, DMSO (99.9%),
sodium cyanoborohydride, cysteine, sodium chloride,
and EDTANa2 were all obtained from Sigma-Aldrich.
Acrylamide and N,N -methylenebisacrylamide were from
BioRad, TEMED (99%), and ammonium persulfate (98%)
were purchased from Sigma-Aldrich. DEAE Sephacel was
from Amersham Biosciences. All other chemicals used were
of analytical reagent grade.
2.2. Harvesting and Tissue Analysis. Porcine hearts from 10–
12-month-old pigs with weights ranging from 160 to 180kg
were obtained from a local slaughterhouse. Within 2 hours
from death, 12 dissected heart valve conduits, aortic and
pulmonary roots (AR and PR), as well as a pool of pericardia
(n = 6), were harvested and decellularized according to a
previously described detergent-based procedure [26]. The
pool of pericardial tissue was divided into 2 parts. One
was considered as a control and the other subjected to
decellularization. The valve conduits were divided into 2
groups: 12 ARs and 12 PRs; for each group 6 samples were
considered as control and referred to as NT and 6 samples
decellularized with Triton X-100 and Sodium Cholate and
referred to as TriCol.
NT samples were rinsed in isotonic saline solution
and immediately processed. Brieﬂy, TriCol samples were
extracted in hypotonic solution using 1% (w/v) Triton X-
100 in presence of protease inhibitors (PI) at 4◦C. Following
treatment in hypertonic conditions, tissues are extracted in
10mM sodium cholate at room temperature [26, 27]. After
extensive washings for detergent removal, each AR and PR
sample was cut into three zones corresponding to: aortic
and pulmonary wall, sinus area, and leaﬂet. Fatty adherencesBiochemistry Research International 3
were removed from pericardia by gentle peeling. Wet weight
of each valve conduit component and pericardial sample was
determined after gently blotting with ﬁlter paper (Whatman
ﬁlter 147 paper number 3). Valve and pericardial minced
t i s s u e sw e r ed e h y d r a t e dw i t h2 0v o l u m e so fa c e t o n ea t4 ◦C
for 24h, defatted with 20 volumes of chloroform: methanol
(2:1, vol/vol) at 4◦C for 24h, dried for 24h at 60◦Ca f t e r
centrifugationat3300×gfor15minutes,andﬁnallyweighed
(dry-defatted tissue (DDT) weight).
2.3. Extraction and Puriﬁcation of Total GAGs. DDTs
(100mg) were rehydrated for 24h at 4◦Ci n0 . 1Ms o d i u m
acetate, pH 6.0, containing 5mM cysteine, and 5mM
ethylenediaminetetraacetic acid (37 volumes per gram of
DDT). Then, papain (0.3U/mg of DDT) was added to
the mixture, which was incubated at 56◦Cf o r4 8 hu n d e r
mild agitation. The digest was clariﬁed by centrifugation
(9000×gf o r2 0 m i na t+ 4 ◦C). Digest supernatant was
loaded on a (diethylamino)ethyl-cellulose column (0.7 ×
6cm, 2.3mL), equilibrated with 50mM sodium acetate,
pH 6.0. The column was then washed with 50mL of the
same buﬀer and eluted with a two-step salt gradient (0.55
and 1.0M NaCl). Fractions of 1mL were collected and
assayed for hexuronate content by the method of Bitter and
Muir, using glucuronolactone as a standard [28]. Total GAG
concentrations were estimated by summing the contents of
the two elution steps. Fractions containing GAGs from both
elution steps were pooled and precipitated using 4 volumes
of cold absolute ethanol. The mixture was left overnight at
−20◦C, and the precipitate was separated by centrifugation,
washed twice with ethanol, and then dried.
2.4. Fluorophore-Assisted Carbohydrate Electrophoresis
(FACE) Analysis. FACE was used to analyze the quantity and
ﬁne structure of the diﬀerent GAG classes, mainly HA and
chondroitin/dermatan sulfates (CS/DS). This technology
can quickly provide characteristics about the sulfation and
iduronation patterns of GalAGs, providing clues to the
identiﬁcation of particular PGs within valve tissues. The
enzymes used for the degradation of the CS isomers belong
to the family of chondro/dermato lyases. Chondroitinase
ABC cleaves the glycosidic bond between hexosamine and
glucuronate (GlcA) so degrading hyaluronan (HA) and all
chondroitinsulfateisomers(CSA,CSC,andDS),producing
disaccharide units containing α, β-unsaturated hexuronic
acids: ΔDi-0SHA, ΔDi-0SCS, ΔDi-mono4S, ΔDi-mono6S.
Chondroitinase AC II acts on the same bond, but it is not
able to cleave glycosidic bond between hexosamine and
iduronate (IdoA), so it completely degrades the CS chains
and, to some extent, the DS ones. In the present paper, CS is
deﬁned as only containing glucuronate, while DS is deﬁned
as containing some quantity of iduronate.
Dried GAGs were dissolved in 100μL of 100mM ammo-
nium acetate, pH 8.0. Separate digestions with chondroitin
ABC and AC II lyases were performed at 37◦C for 24h, using
0.1U per 100μg hexuronic acid. The digestion mixture was
boiled for 1min to inactivate the enzyme, centrifuged at
11000×g for 5min, and vacuum-dried. The free reducing
groups exposed by enzyme cleavage can be ﬂuorescently
tagged with 2-aminoacridone (AMAC) by reductive amina-
tion in presence of sodium cyanoborohydride (NaBH3CN)
[29, 30]. This method allows the labeling of the reducing
ends of unsaturated disaccharides obtained after enzymatic
degradation of GAG chains, improving dramatically the
sensitivity of various analytical techniques used for identi-
ﬁcation and quantitation of GAGs [30, 31].
Brieﬂy,40μLof12.5mMAMACsolutioninglacialacetic
acid/DMSO (3:17v/v) was added to the lyophilized sample
aliquots, and samples were incubated for 10–15 minutes
at room temperature. Then 40μL of 1.25M NaBH3CN in
ultrapure water was added to each sample, and the mixtures
were incubated at 45◦C for 4 hours. After derivatization,
20μL of glycerol (20% ﬁnal concentration) was added to
each sample prior electrophoresis. PAGE was performed
according to Karousou et al. [31], in a Mini-Protean II
cell vertical slab gel electrophoresis apparatus (Bio-Rad).
Electrophoresis was performed in 0.15M Tris-borate, pH
8.8, at 400V and 4◦C. Gels were scanned in a UV-light box
using a CCD camera (Gel Doc XR System) and analyzed
with Quantity One 4.6.3 from Bio-Rad Laboratories. For
quantitation of Δ-disaccharides, a CS calibration curve was
built using commercial chondroitin sulfate A subjected to
chondroitin ABC and AC lyase treatment and derivatization
procedure.
The ratios of glucuronate to iduronate containing disac-
charides and 4-sulfation to 6-sulfation were calculated.
T h eG A Gc l a s sl e v e l sf r o me a c hs a m p l ea sm e a s u r e db y
FACE were normalized to the DDT weight to estimate the
tissue concentrations.
2.5. Isolation and Seeding of Bovine Fibroblasts on TriCol-
Treated Pericardium. Bovine ﬁbroblasts were isolated from
bovine pericardium by 2mg/mL collagenase II digestion
and cultured in DMEM HEPES (Sigma, St.Louis, USA)
modiﬁcation (10% FBS, 1% glutamine, and 1% peni-
cillin/streptomycin) at 37◦C and 5% CO2. Cells were left in
culture up to the 3rd passage.
Seeding was performed on 1.77cm2 of circle-shaped
TriCol-treated pericardium samples in 24-well ﬂat bottom-
culture plate (BD, NJ, USA). Suspension of 750,000 cells/cm2
in1mLDMEMHEPES(Sigma,St.Louis,USA)modiﬁcation
(10% FBS, 1% glutamine, and 1% penicillin/streptomycin)
was distributed onto each pericardial sample. After 7 days
of culture in incubator, the specimens were collected and
processed for histological evaluation.
2.6. Histological Staining. To assess the presence, surface
spreading and penetration of ﬁbroblasts after seven days in
vitro culture on TriCol-treated pericardium, specimens were
embedded in Optimal Cutting Temperature Medium (OCT
Bioptica, Milano, Italy), sectioned at 8μm and stained for
hematoxylin and eosin (H and E) (Rapid Frozen Section Kit,
Bioptica, Milano, Italy).
2.7. Mechanical Testing. Stress-strain tests of native and
decellularized bovine pericardium were performed in a
tensiometer Zwich Z0.5 (Brugger HSG/ETK). For both
nativeandTriCol-treatedpericardium,bone-shapedsamples4 Biochemistry Research International
Table 1: Total GAG content (μg hexuronate/mg DDT) in the selected areas of cardiac valves and in pericardial tissue (before and after TriCol
treatment).
Aortic valve Pulmonary valve Pericardium
Leaﬂet Sinus Wall Leaﬂet Sinus Wall
NT 17.50 ±5.55 18.21 ±11.57 5.74 ±3.72 9.11 ±5.02 5.66 ±0.94 4.18 ±1.09 2.34∗
TriCol 4.88 ±3.43 5.61 ±2.16 2.74 ±0.60 4.61 ±1.23 2.62 ±0.95 2.82 ±0.87 1.44∗
∗pooled samples.
were excised from the pericardial area facing the left ventricle
anterior wall and with the main axis orthogonal to the
interventricular septum. The area of the specimens free from
the grips was a rectangle with a length of 34mm and a
width of 6mm. The thickness of the specimen was measured
with a digital thickness gauge and used to calculate the
cross-sectional area. The mechanical tests were performed
in physiological solution at RT, and for every sample an
elongation of 30mm/m was applied bringing the tissue to
rupture. Data of elongation and force applied were collected
every second.
2.8. Statistical Analysis. Data are reported as mean ± stan-
dard deviation or total numbers and relative frequencies.
For comparison between two groups, Student’s t-test was
performed. A value of P ≤ 0.05 was considered statistically
signiﬁcant. The analyses were performed with Microsoft
SPSS 11.0 and SigmaStat 3.11.0 software.
3. Results
In the three conduit tissues (leaﬂet, sinus, and wall) of both
NT AR and PR, the diﬀerential concentration of total GAGs
(normalized to DDT) was in turn deeply diﬀerent from
that in pericardium (Table 1). Particularly, in AR, the GAG
contentofleaﬂetandsinuswassimilarandthreetimeshigher
than that of arterial wall. However, in PR GAG content of
leaﬂet was twice that found in both sinus and pulmonary
arterial wall. Otherwise, by comparing the two valvulated
conduits, GAG concentration in AR leaﬂet resulted twice
that in PR leaﬂet while that in aortic wall was similar to
that in pulmonary artery wall. In turn the GAG content of
pericardium accounted to about half that in the arterial wall
of both valvulated conduits.
TriCol-based decellularization procedure produced a
relevant loss of GAGs. Relative to native aortic valve, the
total GAG content in TriCol-decellularized specimens was
reduced by 72% in leaﬂet, 69% in sinus, and 52% in arterial
wall. For pulmonary valve, total GAG reduction was by 49%
in leaﬂet, 53% in sinus, and 33% in wall. In pericardial
samples, decellularization reduced total GAG concentration
by 39%.
As already reported in a previous paper [26], GAG
distribution was partly diﬀerent in each diﬀerent portion
(leaﬂet, sinus, and wall) of NT AR and PR. In both
conduits chondroitin sulfate (CS) isomers and hyaluronan
were present in the greatest proportion, the hyaluronan
exhibiting a decreasing gradient from leaﬂet to arterial wall.
Moreover, in leaﬂets and sinuses of both valves CS isomers
STD
Low charge High charge Low charge
AC ABC ABC AC ABC AC
ΔDi-6S
ΔDi-4S
ΔDi-2S
ΔDi-di(4,6)S
ΔDi-di(2,4)S
ΔDi- HA 0S
ΔDi- CS 0S
Figure 1: Representative FACE separation of unsaturated AMAC-
labeled disaccharides obtained from low- (0.55M NaCl) and high-
charged (1M NaCl) GAGs after depolymerization with Chase ABC
and AC.
comprised a slow migrating CS, as assessed by acetate
cellulose electrophoresis of free intact polysaccharides.
Inpericardium,theGAGclasspresentinthegreatestpro-
portion was dermatan sulfate (DS), with very low amounts
of hyaluronan, as assessed by discontinuous electrophoresis
of intact chains (data not shown).
3.1. GAG Structural Analysis. Since the relative proportion
of HS in sinuses and leaﬂets of native cardiac valves and
in pericardium was very low, we focused on the structural
characterization of CS isomers puriﬁed from NT and TriCol
samples. FACE analysis allows us to detect both mono- and
di-sulfated CS-derived disaccharides, also discriminating
between the nonsulfated forms released from CS isomers
and those from HA (Figure 1). The distributions of Δ-
disaccharides in porcine cardiac valves were similar in each
selected portion of aortic and pulmonary conduits, while
pericardial tissue contained an abundance of ΔDi-mono4S
and ΔDi-diS with very low proportions of nonsulfated and 6
sulfated Δ-disaccharides (Figure 2).
There were no signiﬁcant changes in Δ-disaccharides
distributions in each sample following decellularization,
even if in aortic leaﬂet and pericardium the loss seems to
aﬀect mainly HA.
The data analyses on ABC/ACII depolymerization
revealed that in valve leaﬂets and sinuses CS was the gal-
actosaminoglycan present in the greatest proportions, while
pericardial tissue had almost exclusively DS (Figure 3).
Statistical analysis of the FACE results relative to GalAG
structural characterization in native and decellularized valveBiochemistry Research International 5
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Figure 2: Relative Δ-disaccharides content in fresh (NT) and decellularized (TriCol) porcine heart valves and pericardium, as calculated
from FACE data.
and pericardium indicated that the depletion in total content
does not produce signiﬁcant changes in the distribution of
CS isomers. The percentages of nonsulfated disaccharides
from CS isomers are reported in Table 2. Interestingly,
signiﬁcant diﬀerences in the under-sulfation degree were
detected comparing native aortic and pulmonary valve
conduits, referred to leaﬂet and sinus.
Additional data like epimerization and sulfation patterns
ofCSisomerswerecalculatedcomprehensivelyonnativeand
treated samples (Table 3). Aortic leaﬂet and sinus showed a
higher proportion of CS respect to the pulmonary ones, a
value that was the opposite to that in the artery wall, while in
the pericardial tissue, as already stated, the major CS isomer
was DS.
3.2. Histology. H and E staining highlighted the removal of
residentcellsfrombovinepericardiumafterTriColtreatment
(Figure 4(b)) compared to native tissue (Figure 4(a)). The
collagen ﬁbers of the resulting matrix exhibited many void
areas surrounding the bundles exhibiting a more deﬁned
wavy pattern (even if partially shrinked) with respect to the
native sample. Seven days after seeding the ﬁbroblasts did
adhere to, crowded the pericardial surface and started to col-
onize the underlying detergent-treated matrix (Figure 4(c)).
Moreover, the collagen ﬁber bundles apparently resumed
morphological features approaching those of the native
sample.
The propensity of TriCol-treated porcine heart valve
leaﬂet to be repopulated by in vitro seeded cells has been
previously reported [27, 32].
4.MechanicalTesting
A typical stress-strain diagram of native and decellularized
pericardial samples is reported in Figure 5. Load-bearing
ﬁbrous component of treated pericardium appeared to be
tensioned at lower strain with respect to those of native
sample as having been partly reoriented in the direction of
the stress. Nevertheless in its linear part the slope of the
diagram was similar in both preparations even if the load
at rupture of TriCol samples accounted to about half that of
native ones.6 Biochemistry Research International
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Figure 3: Distribution of glycosaminoglycans (GAGs) in NT and TriCol-treated porcine valves and pericardium, as calculated from FACE
data. G0S: nonsulfated GlcA-containing disaccharides, G6S: 6-sulfated GlcA-containing disaccharide, G4S: 4-sulfated GlcA-containing
disaccharide, G(4,6)S: disulfated GlcA-containing disaccharide, I0S: nonsulfated IdoA-containing disaccharide, I6S: 6-sulfated IdoA-
containing disaccharide, I4S: 4-sulfated IdoA-containing disaccharide, I(4,6)S: disulfated IdoA-containing disaccharide.Biochemistry Research International 7
Table 2: Percentages of nonsulfated disaccharides from CS isomers in the examined tissues (means ± SD). Signiﬁcant diﬀerences (P<0.05)
are reported in bold.
ΔDi-nonsulfated/total Δ-disaccharides
NT TriCol
Pericardium 0.019 0.017
Aortic valve
NT TriCol P
Leaﬂet 0.177 ±0.031 0.150 ±0.024 0.228
Sinus 0.237 ±0.031 0.158 ±0.056 0.061
Artery wall 0.028 ±0.016 0.048 ±0.040 0.404
Pulmonary valve
NT TriCol P
Leaﬂet 0.100 ±0.017 0.090 ±0.020 0.463
Sinus 0.129 ±0.021 0.086 ±0.029 0.070
Artery wall 0.029 ±0.019 0.018 ±0.004 0.380
Aortic versus pulmonary
NT TriCol
Leaﬂet 0.005 0.008
Sinus 0.001 0.117
Artery wall 0.938 0.274
Table 3: Levels of epimerization and sulfation of CS isomers (means ± SD).
CS/DS CS DS Total GalAGs (CS + DS)
Aortic valve GlcA/IdoA 4S/6S 4S/6S 4S/6S
Leaﬂet 1.666 ±0.645 0.375 ±0.072 2.340 ±0.699 0.823 ±0.121
Sinus 2.611 ±0.908 0.397 ±0.072 2.359 ±1.175 0.724 ±0.077
Artery wall 1.446 ±0.843 0.644 ±0.111 2.221 ±0.910 0.971 ±0.074
Pulmonary valve
Leaﬂet 1.180 ±0.404 0.412 ±0.087 2.605 ±0.759 1.304 ±0.525
Sinus 1.476 ±0.673 0.589 ±0.429 3.995 ±0.665 1.273 ±0.190
Artery wall 3.133 ±0.777 0.681 ±0.103 1.982 ±0.760 0.905 ±0.074
Pericardium∗ 0.017 ∗∗ 80.289
∗Single data regarding C4S/C6S and D4S/D6S for pericardium were very high, as 6-sulfation was near to 0.
(a) (b) (c)
Figure 4: H and E staining of native bovine pericardium (a); TriCol-decellularized bovine pericardium before (b) and after 7 days of bovine
ﬁbroblasts seeding (c). Magniﬁcation 20x.8 Biochemistry Research International
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Figure 5: Stress-strain diagram of native and TriCol-decellularized
bovine pericardium strips. See Section 2.
The mechanical properties of TriCol-treated valvular
leaﬂets from pigs have been previously reported [27]t ob e
not signiﬁcantly diﬀerent from those of untreated samples
although circumferential samples exhibited 20% higher
extensibility and trended to lower (about 10%) stiﬀness.
5. Discussion
Recentdecellularizationstudiescomprisingourcombination
of ionic and nonionic detergents showed excellent cell
removal capacity with preservation of the major structural
ECM molecules although ionic detergents like sodium-
dodecyl-sulfate (SDS) and sodium deoxycholate (DOC)
might somehow modify the resulting scaﬀold matrix [33,
34]. Particularly, the adopted TriCol procedure is reported
to thoroughly remove the α-gal antigen responsible for
the iperacute rejection of xenogenic grafts and possibly for
the chronic inﬂammation elicited by bioprosthetic devices
treated with glutaraldehyde [35].
However, the loss of GAGs following decellularization
could have deep eﬀects on the structure of the ECM. In
fact, the extraction of the GAGs could aﬀect the mechanical
behavior of the valves by introducing ﬂexural rigidity,
thickness decrease and favoring an increase in tissue Ca2+
content. All of these changes in the ECM composition might
lead to problems in valve functionality or directly in valve
failure.Inthispaper,ﬂuorophore-assistedcarbohydrateelec-
trophoresis(FACE)wasusedtoprovidedetailedinformation
regarding GAG distribution as well as quantity and ﬁne
structure of various GAGs in porcine vascular tissues (aortic
valve, pulmonary valve, and pericardium) used as xenografts
for heart valve implants.
This study showed that the content and distribution
of GAGs within native aortic valve, pulmonary valve, and
pericardium are deeply diﬀerent. In valve conduits both
levels and composition of GAGs were region-speciﬁc. The
leaﬂets, which experience compression, contain the highest
concentration of GAGs, with an abundance of HA and
under-sulfated CS. The quantiﬁcation and characterization
of GAGs in porcine valve conduits by FACE largely agree
with our previous results obtained by analyzing intact
polysaccharides [26]. The pericardial tissue contains rela-
tively fewer GAGs but higher proportions of dermatan-4-
sulfated and dermatan oversulfated. Particularly the level of
oversulfation is strikingly higher than that already reported
for oversulfated DS from other porcine tissues (e.g., up to
10–20% in skin) which in turn exhibit signiﬁcant HC-II-
mediated inhibition of thrombin activity [36]. Noteworthy,
the oversulfation level found here is comparable to that
of DS from marine ascidians (50–70%) also studied for
its thrombin inhibitory activity [37]. All that could be the
rationale behind the still unexplained low thrombogenicity
potential of pericardial valve xenografts making the chronic
anticoagulation treatment unnecessary in such patients [38].
Moreover, this ﬁnding is in good agreement with published
datawhichdescribedthepresenceofalow-molecular-weight
dermatan sulfate proteoglycan in bovine pericardial tissue
[39]. The abundance of particular GAGs and PGs can
vary according to diﬀerent biological needs of the tissues.
In example, the dermatan sulfate (mostly 4-sulfated) PGs
decorin and biglycan regulate the formation and orientation
of collagen ﬁbrils and hence tissue tensile strength, whereas
the hyaluronan (HA), which is not covalently bound to a
core protein, entraps large amounts of water to create a
swelling force [40, 41]. It has been speculated that their
ability to hydrate the spongiosa layer serves to decrease the
shear stresses during valve function, and the presence of
negatively charged GAG molecules may reduce calciﬁcation
by chelating calcium ions, thereby preventing hydroxyap-
atite nucleation [13, 14, 42]. Moreover, it is thought that
decellularization treatment extracts more easily hyaluronan
andchondroitin/dermatan-6-sulfate,whichexistintissuesas
part of the aggregate of hyaluronan and versican PG [43].
These observations suggest that the loss of GAGs may be
crucial for the development of new bioprostheses.
Our results showed that there was a relevant extraction
of GAGs following TriCol decellularization procedure, but it
was not selective, with the only exception of HA from aortic
leaﬂet and pericardium. Distribution of PGs and GAGs in
vasculartissue has been reported to be complex, district- and
layer-speciﬁc, associated with diﬀerent mechanical environ-
ments [11], and could have important implications for heart
valve tissue engineering and bioprosthesis development.
Although some of these compositional diﬀerences may
appear quite subtle, such as the degree and position of
sulfate and the degree and position of 5 epimerization on
sulfated GAG chains, these ﬁne structural distinctions may
have important biological roles such as binding sites for
other matrix components or for signaling cell diﬀerentiation
in addition to their possible inﬂuence on the scaﬀold
thrombogenicity. The possibility to assess carefully the ΔDi-
mono4S and ΔDi-mono6S content in tissues is important
considering that modiﬁcations of the ΔDi-mono4S/Δdi-
mono6S ratio and the ratio of nonsulfated to sulfated GAGsBiochemistry Research International 9
have been described in aging and disease. The C4S/C6S
ratio has important biological implication; in humans, it
decreases progressively in pulmonary artery, iliac artery, and
aorta [44]. Moreover, the relative content of C4S decreases
about ﬁvefold in human aorta [45] and cerebral arteries [46]
with aging and C4S/C6S ratio decreases particularly with
atherosclerosis development [47].
Furthermore, this ratio might gather more information
about the mechanical behavior and hence, be used to
hypothesize the type of PGs found in the valves associated to
GAG class concentrations and ﬁne structure characteristics
[10, 11].
H and E staining showed that TriCol procedure did in
fact remove the cells from the native pericardium while the
resulting matrix revealed to be suitable for cell repopulation.
The ﬁbroblasts adhered to the pericardial surface and
started, after 7-day culture, to spread into the underlying
extracellular matrix. Removal of cells did modify partly the
mechanics of the native pericardium while being otherwise
compatiblewiththefeaturesexpectedforthemakingofvalve
substitutes although the ultimate mechanical behaviour of
repopulated scaﬀolds has still to be explored. As a whole
both TriCol-decellularized porcine heart valves and bovine
pericardium appeared a promising material bearing the
potential for future development of tissue-engineered heart
valve scaﬀolds able to be recellularized by the patient own
cells.
Future studies are expected to examine the inherent
complexitywithinvalvetissues,duetothehistological layers,
mechanical forces, matrix composition and eﬀects of aging,
and also the functional characteristic of diﬀerent GAGs that
could have impact on the function of normal valves and on
the choice of the candidate cardiovascular tissue to produce
the best scaﬀold for the development of a tissue-engineered
heart valve.
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